Comerica Bank Repligen Corp Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Repligen Corp stock. As of the latest transaction made, Comerica Bank holds 85,023 shares of RGEN stock, worth $14.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

85,023

Previous 147,910 42.52%

Holding current value

$14.2 Million

Previous $18.6 Million 32.14%

% of portfolio

0.05%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $7.53 Million - $10.5 Million	-62,887 Reduced 42.52%	85,023 $12.7 Million
Q2 2024 Aug 15, 2024	BUY	$120.0 - $182.95 $2.99 Million - $4.55 Million	24,889 Added 20.23%	147,910 $18.6 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $698,490 - $852,437	-4,090 Reduced 3.22%	123,021 $22.6 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $1.28 Million - $2.07 Million	11,182 Added 9.65%	127,111 $22.9 Million
Q3 2023 Nov 21, 2023	BUY	$138.78 - $176.51 $14.9 Million - $19 Million	107,399 Added 1259.07%	115,929 $18.4 Million
Q2 2023 Aug 22, 2023	SELL	$138.42 - $180.31 $15.1 Million - $19.7 Million	-109,152 Reduced 92.75%	8,530 $6,000
Q4 2022 Jan 26, 2023	BUY	$162.42 - $220.56 $2 Million - $2.71 Million	12,309 Added 11.68%	117,682 $0
Q3 2022 Oct 28, 2022	SELL	$160.42 - $256.21 $2.44 Million - $3.9 Million	-15,204 Reduced 12.61%	105,373 $17.7 Million
Q2 2022 Aug 02, 2022	BUY	$140.68 - $188.02 $1.79 Million - $2.39 Million	12,735 Added 11.81%	120,577 $20.3 Million
Q1 2022 Apr 27, 2022	BUY	$161.19 - $257.96 $5.3 Million - $8.47 Million	32,850 Added 43.8%	107,842 $20.3 Million
Q4 2021 Feb 18, 2022	SELL	$247.59 - $304.47 $4.93 Million - $6.06 Million	-19,899 Reduced 20.97%	74,992 $19.9 Million
Q3 2021 Nov 22, 2021	SELL	$194.77 - $324.21 $1.54 Million - $2.56 Million	-7,882 Reduced 7.67%	94,891 $27.4 Million
Q2 2021 Aug 26, 2021	BUY	$165.87 - $220.95 $416,167 - $554,363	2,509 Added 2.5%	102,773 $20.5 Million
Q1 2021 Apr 28, 2021	BUY	$180.37 - $226.26 $359,477 - $450,936	1,993 Added 2.03%	100,264 $19.5 Million
Q4 2020 Jan 28, 2021	SELL	$148.08 - $206.57 $727,220 - $1.01 Million	-4,911 Reduced 4.76%	98,271 $18.8 Million
Q3 2020 Oct 30, 2020	BUY	$122.51 - $158.27 $3.07 Million - $3.97 Million	25,071 Added 32.1%	103,182 $15.2 Million
Q2 2020 Jul 31, 2020	SELL	$94.33 - $140.48 $1.55 Million - $2.3 Million	-16,407 Reduced 17.36%	78,111 $9.66 Million
Q1 2020 May 01, 2020	BUY	$84.96 - $109.14 $821,308 - $1.06 Million	9,667 Added 11.39%	94,518 $9.12 Million
Q4 2019 Feb 07, 2020	BUY	$73.84 - $93.08 $960,953 - $1.21 Million	13,014 Added 18.12%	84,851 $7.85 Million
Q3 2019 Oct 31, 2019	SELL	$76.65 - $95.51 $392,294 - $488,820	-5,118 Reduced 6.65%	71,837 $5.51 Million
Q2 2019 Aug 02, 2019	BUY	$54.2 - $85.95 $30,352 - $48,132	560 Added 0.73%	76,955 $0
Q1 2019 May 02, 2019	BUY	$49.45 - $62.8 $90,839 - $115,363	1,837 Added 2.46%	76,395 $0
Q4 2018 Feb 06, 2019	BUY	$48.26 - $68.88 $204,670 - $292,120	4,241 Added 6.03%	74,558 $4.07 Million
Q3 2018 Nov 01, 2018	SELL	$46.8 - $58.97 $90,370 - $113,871	-1,931 Reduced 2.67%	70,317 $3.95 Million
Q2 2018 Aug 01, 2018	SELL	$35.26 - $47.04 $86,986 - $116,047	-2,467 Reduced 3.3%	72,248 $3.47 Million
Q1 2018 May 01, 2018	BUY	$30.92 - $37.27 $347,138 - $418,430	11,227 Added 17.68%	74,715 $2.8 Million
Q4 2017 Feb 02, 2018	BUY	$32.53 - $38.92 $370,028 - $442,715	11,375 Added 21.83%	63,488 $2.33 Million
Q3 2017 Nov 06, 2017	BUY	$36.98 - $46.06 $1.93 Million - $2.4 Million	52,113	52,113 $2.01 Million

Others Institutions Holding RGEN

# of Institutions

489

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.26B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account